These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38843472)

  • 41. A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somatically.
    Coffee B; Cox HC; Bernhisel R; Manley S; Bowles K; Roa BB; Mancini-DiNardo D
    Hum Mutat; 2020 Jan; 41(1):203-211. PubMed ID: 31490007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative.
    Pearlman R; Frankel WL; Swanson BJ; Jones D; Zhao W; Yilmaz A; Miller K; Bacher J; Bigley C; Nelsen L; Goodfellow PJ; Goldberg RM; Paskett E; Shields PG; Freudenheim JL; Stanich PP; Lattimer I; Arnold M; Prior TW; Haut M; Kalady MF; Heald B; Paquette I; Draper DJ; Brell JM; Mahesh S; Weeman K; Bastola S; Zangmeister J; Gowda A; Kencana F; Malcolm A; Liu Y; Cole S; Bane C; Li C; Rehmus E; Pritchard CC; Shirts BH; Jacobson A; Cummings SA; de la Chapelle A; Hampel H
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic Variants in Patients With a Family History of Pancreatic Cancer: Impact of Multigene Panel Testing.
    Zhu H; Welinsky S; Soper ER; Brown KL; Abul-Husn NS; Lucas AL
    Pancreas; 2021 Apr; 50(4):602-606. PubMed ID: 33939675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan.
    Abdel-Razeq H; Al-Omari A; Zahran F; Arun B
    BMC Cancer; 2018 Feb; 18(1):152. PubMed ID: 29409476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With Colorectal Cancer.
    Moretz C; Byfield SD; Hatchell KE; Dalton J; Onglao PN; Hang L; Hansen P; Radford C; Nielsen SM; Heald B; Munro SB; Nussbaum RL; Esplin ED
    JAMA Netw Open; 2022 Oct; 5(10):e2238167. PubMed ID: 36279135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrent TP53 missense mutation in cancer patients of Arab descent.
    Zick A; Kadouri L; Cohen S; Frohlinger M; Hamburger T; Zvi N; Plaser M; Avital E; Breuier S; Elian F; Salah A; Goldberg Y; Peretz T
    Fam Cancer; 2017 Apr; 16(2):295-301. PubMed ID: 27866339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
    Beitsch PD; Whitworth PW; Hughes K; Patel R; Rosen B; Compagnoni G; Baron P; Simmons R; Smith LA; Grady I; Kinney M; Coomer C; Barbosa K; Holmes DR; Brown E; Gold L; Clark P; Riley L; Lyons S; Ruiz A; Kahn S; MacDonald H; Curcio L; Hardwick MK; Yang S; Esplin ED; Nussbaum RL
    J Clin Oncol; 2019 Feb; 37(6):453-460. PubMed ID: 30526229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insurance coverage does not predict outcomes of genetic testing: The search for meaning in payer decisions for germline cancer tests.
    Amendola LM; Hart MR; Bennett RL; Horike-Pyne M; Dorschner M; Shirts B; Jarvik GP
    J Genet Couns; 2019 Dec; 28(6):1208-1213. PubMed ID: 31317629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic Testing Utilization: Discrepancies Between Somatic and Germline Results in Patients With Cancer Reviewed at the UW Health Precision Medicine Molecular Tumor Board.
    Horn IP; Zakas AL; Smith-Simmer KJ; Birkeland LE; Sundstrom R; Burkard ME; Weiss JM
    JCO Precis Oncol; 2024 May; 8():e2300466. PubMed ID: 38810171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
    Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
    Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients.
    LaDuca H; Polley EC; Yussuf A; Hoang L; Gutierrez S; Hart SN; Yadav S; Hu C; Na J; Goldgar DE; Fulk K; Smith LP; Horton C; Profato J; Pesaran T; Gau CL; Pronold M; Davis BT; Chao EC; Couch FJ; Dolinsky JS
    Genet Med; 2020 Feb; 22(2):407-415. PubMed ID: 31406321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trials.
    McVeigh TP; Sundar R; Diamantis N; Kaye SB; Banerji U; Lopez JS; de Bono J; van der Graaf WTA; George AJ
    Eur J Cancer; 2018 May; 95():20-29. PubMed ID: 29614442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.
    Walker EJ; Carnevale J; Pedley C; Blanco A; Chan S; Collisson EA; Tempero MA; Ko AH
    Fam Cancer; 2019 Apr; 18(2):241-251. PubMed ID: 30267352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma.
    AlDubayan SH; Conway JR; Camp SY; Witkowski L; Kofman E; Reardon B; Han S; Moore N; Elmarakeby H; Salari K; Choudhry H; Al-Rubaish AM; Al-Sulaiman AA; Al-Ali AK; Taylor-Weiner A; Van Allen EM
    JAMA; 2020 Nov; 324(19):1957-1969. PubMed ID: 33201204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
    Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
    Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. UK recommendations for
    Hanson H; Durkie M; Lalloo F; Izatt L; McVeigh TP; Cook JA; Brewer C; Drummond J; Butler S; Cranston T; Casey R; Tan T; Morganstein D; Eccles DM; Tischkowitz M; Turnbull C; Woodward ER; Maher ER;
    J Med Genet; 2023 Feb; 60(2):107-111. PubMed ID: 35260474
    [No Abstract]   [Full Text] [Related]  

  • 58. The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients.
    Bernstein-Molho R; Barnes-Kedar I; Ludman MD; Reznik G; Feldman HB; Samra NN; Eilat A; Peretz T; Peretz LP; Shapira T; Magal N; Kalis ML; Yerushalmi R; Vinkler C; Liberman S; Basel-Salmon L; Shohat M; Levy-Lahad E; Friedman E; Bazak L; Goldberg Y
    Breast Cancer Res Treat; 2019 Nov; 178(1):231-237. PubMed ID: 31368036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic association analysis of ERBB4 polymorphisms with the risk ofschizophrenia susceptibility in a Jordanian population of Arab descent.
    Al-Eitan L; Al-Habahbeh S; Alkhatib R
    Turk J Med Sci; 2017 Apr; 47(2):542-553. PubMed ID: 28425244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care.
    De Silva DL; Stafford L; Skandarajah AR; Sinclair M; Devereux L; Hogg K; Kentwell M; Park A; Lal L; Zethoven M; Jayawardana MW; Chan F; Butow PN; James PA; Mann GB; Campbell IG; Lindeman GJ
    Med J Aust; 2023 May; 218(8):368-373. PubMed ID: 37005005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.